Health care M&A off to a strong start in 2011

July 2011
New Hampshire Business Review;7/1/2011, Vol. 33 Issue 13, p26
The article focuses on the merger and acquisition activity in the health care sector in the U.S. It is said that market confidence has yet not recovered completely, but corporate and private equity players are once again looking for the deals in biotechnology, life sciences, pharmaceuticals and hospitals sector. It is said that the merger activities are also being supported by the President Barack Obama's enactment of the Patient Protection and Affordable Care Act.


Related Articles

  • A RETURN TO HEALTH. HOLMAN, KELLY // Investment Dealers' Digest;12/8/2008, Vol. 74 Issue 47, p16 

    The article focuses on the inclinations of private-equity investors in the healthcare industry. It reports on the opportunities available for the private-equity investors in the healthcare merger & acquisition (M&A) sector. Large phramaceutical and healthcare product companies are availing the...

  • Research & Markets: Partnerships, Licensing, Investments, M & A Deals & Trends in Pharmaceuticals - Q1 2011.  // Biomedical Market Newsletter;5/16/2011, p33 

    The article reports on GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011" report, which was added to the services being offered by Research & Markets Ltd. It says that the report provides information on mergers and acquisitions (M&A),...

  • Mergers Rebound in 4Q. Holman, Kelly // High Yield Report;1/11/2010, Vol. 21 Issue 2, p27 

    The article reports on the rise of global mergers and acquisitions (M&A) in the fourth quarter of 2009 according to mergermarket. Bankruptcy-related M&A surged by 370% to 543. But the volume is 27% lower when compared to the same 2008 period despite the increase in value. The total value of all...

  • Big Pharma's Mid-Market Influence. Marino, Jonathan // Investment Dealers' Digest;5/1/2009, Vol. 75 Issue 17, p24 

    The article discusses optimism among mid-market dealmakers in the U.S. It focuses on the belief of mid-market dealmakers in private equity that mergers and acquisitions beginning to penetrate in the pharmaceutical industry will result in opportunities for them. The opportunities might include...

  • Part Two: Sector Overviews: Pharmaceuticals.  // Doing Business with Jordan;2004, p172 

    The article presents the pharmaceutical industry in Jordan as of 2004. The challenges faced by the industry are discussed. Mergers and joint ventures of pharmaceutical companies are evaluated. Foreign investments in the industry are assessed.

  • How They Fit. Young, Peter // Pharmaceutical Executive;May2007, Vol. 27 Issue 5, p122 

    The article discusses the trends of the global pharmaceutical industry during 2006. A survey from Young & Partners indicated that U.S. pharmaceutical companies had a good year for 2006, while European firms ended up with underperformance on the same period. Meanwhile, pharmaceutical acquisitions...

  • PRIVATE EQUITY: THE ART OF THE DEAL. Valenza, Tor // Imaging Economics;Aug2007, Vol. 20 Issue 8, p26 

    The article reports on the benefits of outpatient imaging centers from investing in private equity firms in connection with the implementation of the Deficit Reduction Act (DRA) in the U.S. It shows that private equity firms help imaging entrepreneurs to finance acquisitions and enhance their...

  • The Private Equity/Healthcare Equation. Abrams, Sandra Lea // Investment Dealers' Digest;11/15/2004, Vol. 70 Issue 44, p24 

    Reports that private equity firms have found hospital companies favorable for investments in the U.S. Implications of rising prices on hospital deals; Indications showing that leveraged buyouts are on the rise; Significance of the private equities of hospitals on health care industry.

  • Mid Europa Acquires Polish Centrum Medyczne.  // EmergingMarketsNOW;4/25/2008, p4 

    The article reports on the acquisition of Centrum Medyczne LIM (CM LIM) by Mid Europa Partners. PricewaterhouseCoopers and Linklaters acted as the advisors to Mid Europa Partners for the deal. CM LIM is a private health care provider in Poland, while Mid Europa is a private equity firm that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics